Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Experiences in C.D.T. testing.

J W Roberts1

  • 1GIB Laboratories New Providence, New Jersey, USA.

Journal of Insurance Medicine (New York, N.Y.)
|February 1, 1997
PubMed
Summary
This summary is machine-generated.

Carbohydrate deficient transferrin (CDT) testing accurately detects alcohol abuse. GIB Laboratories

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Successful treatment of a case of Cynanche Laryngea.

Medico-chirurgical transactions·2010
Same author

A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2.

Neurology·2010
Same author

Human PON1, a biomarker of risk of disease and exposure.

Chemico-biological interactions·2010
Same author

High-speed temporal characterization and visualization of spatial light modulators and flat-panel displays.

Optics letters·2007
Same author

Identification and haplotype analysis of LRRK2 G2019S in Japanese patients with Parkinson disease.

Neurology·2006
Same author

A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations.

Neurology·2005
Same journal

Creating Evidence-Based Ratings and Life Expectancies Medical Impairments.

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

The Smoking Dilemma: A Technical Deep Dive.

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

Biological Clocks: Ready for Prime Time?

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

GLP-1 Therapies and Mortality Risk: Implications for Life Insurers.

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

Identifying Benzodiazepine Abuse: A Report of 3 Cases.

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

Between Fear and Adoption: The AI Paradox in Medico-Legal Practice Among National Insurance Physicians.

Journal of insurance medicine (New York, N.Y.)·2026
See all related articles

Area of Science:

  • Biochemistry
  • Clinical Chemistry
  • Toxicology

Background:

  • Carbohydrate-deficient transferrin (CDT) is a validated biomarker for alcohol abuse.
  • Accurate detection of alcohol abuse is crucial for clinical management and public health.
  • Existing confirmatory tests for CDT have limitations in terms of time, cost, and precision.

Purpose of the Study:

  • To validate the performance of a commercial CDT enzyme immunoassay (CDT EIA) for detecting alcohol abuse.
  • To assess the sensitivity, specificity, and reproducibility of the CDT EIA.
  • To determine the utility of confirmatory CDT testing in clinical laboratories.

Main Methods:

  • Validation of the CDT EIA using 184 clinically defined positive and 203 negative serum samples.
  • Application of a defined cutoff and a special testing algorithm for analysis.

Related Experiment Videos

  • Assessment of intra- and inter-run reproducibility.
  • Main Results:

    • The CDT EIA demonstrated a sensitivity of 88% and a specificity greater than 99%.
    • Intra- and inter-run reproducibility were less than 7%, indicating high precision.
    • The assay was approximately three times more precise than most confirmatory CDT tests.

    Conclusions:

    • The CDT EIA is a highly sensitive and specific assay for detecting alcohol abuse.
    • Confirmatory CDT testing is generally not recommended due to the high specificity of the screening assay.
    • Performing confirmatory testing may increase false negatives, offer minimal correction of false positives, and increase costs and delays.